Skip to Content

ViaDerma Inc VDRM Stock Quote

| Rating as of

PINX:VDRM

Morningstar‘s Stock Analysis VDRM

Valuation
Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics VDRM

Company Profile VDRM

Business Description

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the manufacture and sales of pharmaceutical related products in the United States of America. Its main product Vitastem is used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.

Contact
4640 Admiralty Way, Suite 500
Marina Del Rey, CA, 90292
T +1 310 374-6111
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2012
Fiscal Year End Dec 31, 2022
Employees 75